StockData
Abivax S.A. logo

Abivax S.A. (ABVX) income statement

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30
$83.83+1.73 (+2.11%)

Close on Nov 18, 2026Market cap $6.58BP/E –Yield –

See a number that looks wrong?